View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

CooperCompanies Announces Second Quarter 2024 Results

CooperCompanies Announces Second Quarter 2024 Results SAN RAMON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2024. Revenue increased 7% year-over-year to $942.6 million. CooperVision (CVI) revenue up 8% to $635.9 million, and CooperSurgical (CSI) revenue up 6% to $306.7 million.GAAP diluted earnings per share (EPS) of $0.44, up $0.24 or 122% from last year's second quarter.Non-GAAP diluted EPS of $0.85, up $0.08 or 10% from...

 PRESS RELEASE

Celcuity Announces Pricing of Underwritten Common Stock Offering

Celcuity Announces Pricing of Underwritten Common Stock Offering MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the pricing of an underwritten offering of 3,871,000 shares of its common stock at an offering price of $15.50 per share. All of the securities are to be sold by Celcuity. Investors who have agreed to purchase shares in the offering include BVF Partners L.P., a U.S.-based healthcare focused investor, Vivo Capital, Eventide Asset Management,...

 PRESS RELEASE

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for ...

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing The Phase 3 clinical trial will evaluate gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer who are endocrine therapy resistantReceived an additional term loan of approximately $62 million in conjunction with an amendment to an existing debt facility agreement MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (...

 PRESS RELEASE

Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity...

Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement TROY, Mich., May 28, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that after the recent $13.8 million debt-to-equity conversions by CP Acquisitions, LLC and GIC Acquisition, LLC, two entities affiliated with Raymond Chang, Chairman and CEO of Agrify, Agrify has received confirmation from Nasdaq that it has regained compliance with the stockholders’ equity...

 PRESS RELEASE

The Children’s Place, Inc. Issues Chairman’s Letter to Shareholders

The Children’s Place, Inc. Issues Chairman’s Letter to Shareholders SECAUCUS, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands with an industry-leading digital-first model, today announced that Turki S. AlRajhi, Chairman of the Company’s Board of Directors and Chairman and CEO of Mithaq, the Company’s majority shareholder, issued a letter to shareholders of The Children’s Place, Inc. In the letter, Mr. AlRajhi provides brief information about Mithaq’s background and approach; views on The Children’s...

 PRESS RELEASE

CooperCompanies’ 2023 Environmental, Social, and Governance Report Hig...

CooperCompanies’ 2023 Environmental, Social, and Governance Report Highlights Efforts that Benefit People and the Planet SAN RAMON, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today released its . The report showcases the company’s progress on enhancing the health and wellness of people around the world, while doing its part to protect the planet and serve its communities. In 2023, CooperCompanies continued to make its leading healthcare solutions more accessible in underserved communities, made significant investments in learning and development programs for g...

 PRESS RELEASE

Agrify Corporation Announces Approximately $13.8 Million Debt-to-Equit...

Agrify Corporation Announces Approximately $13.8 Million Debt-to-Equity Conversion Company Expects to Regain Compliance with Nasdaq Shareholders’ Equity Requirement TROY, Mich., May 22, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced an approximately $13.8 million debt-to-equity conversion by CP Acquisitions, LLC and GIC Acquisitions LLC. As a result of the conversion, the Company is expected to regain compliance with Nasdaq’s Listing R...

 PRESS RELEASE

The Children's Place, Inc. Announces CEO Transition

The Children's Place, Inc. Announces CEO Transition SECAUCUS, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands with an industry-leading digital-first model, today announced the departure of Jane Elfers, President and CEO, and announced the appointment of Muhammad Umair as the new President and Interim CEO, effective May 20, 2024. The Company thanks Jane for her dedication to the Company and wishes her well in her next chapter. Jane Elfers said, “I want to thank the entire team at The Children’s Plac...

 PRESS RELEASE

Agrify Corporation Announces Results for First Quarter 2024

Agrify Corporation Announces Results for First Quarter 2024 Company achieves near break-even quarterly results TROY, Mich., May 21, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Summary Revenue was $2.6 million for the first quarter of 2024, compared to $5.8 million for the first quarter of 2023.Gross profit was $0.73 million for the fir...

GEO Group, Inc. (The): Covenant Quality Post-Sale Snapshot: $650m 8.62...

The GEO Group, Inc.'s covenant package provides moderate protection, reflecting a CQ score of 3.15.

GEO Group, Inc. (The): Covenant Quality Post-Sale Snapshot: $625m 10.2...

The GEO Group, Inc.'s covenant package provides moderate protection, reflecting a CQ score of 3.30.

 PRESS RELEASE

Agrify Corporation Mutually Agrees to Terminate Plan to Merge with Nat...

Agrify Corporation Mutually Agrees to Terminate Plan to Merge with Nature’s Miracle TROY, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that Agrify Corporation and Nature’s Miracle Holdings Inc. (NASDAQ: NMHI) (“Nature’s Miracle”) have mutually agreed to terminate the agreement and plan of merger, previously announced on May 16, 2024, given unfavorable market conditions. In connection with the termination of the mer...

 PRESS RELEASE

CORRECTION: Magic Software Reports First Quarter 2024 Financial Result...

CORRECTION: Magic Software Reports First Quarter 2024 Financial Results OR YEHUDA, Israel, May 16, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC), please note that the company has updated the dividend payout date. The dividend payable date has been advanced to July 11, 2024, from July 13, 2024. The corrected release is as follows: Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (“the Company”), a global provider of IT consulting services and end-to-end integration and application develo...

 PRESS RELEASE

Magic Software Reports First Quarter 2024 Financial Results

Magic Software Reports First Quarter 2024 Financial Results OR YEHUDA, Israel, May 16, 2024 (GLOBE NEWSWIRE) -- Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (“the Company”), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, announced today its financial results for the first quarter ended March 31, 2024. Summary Results for the First Quarter 2024 (USD in millions, except per share data)        GAAP  Non-GAAP  Q1 2024Q1 2023% Change Q1 2024Q1 2023% ChangeRevenues$130.7$142.4(8.2%) $130.7$142.4(8.2%)Gross prof...

 PRESS RELEASE

Nature’s Miracle and Agrify Corporation Announces Signing of the Defin...

Nature’s Miracle and Agrify Corporation Announces Signing of the Definitive Merger Agreement Transaction Expected to Close in the Second Half of 2024 ONTARIO, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Nature's Miracle Holding Inc. (NASDAQ: NMHI; NMHIW) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology and infrastructure, and Agrify Corporation (NASDAQ: AGFY) (“Agrify”), announced today that both parties have signed a definitive agreement and plan of merger (“Agreement”) in which a new wholly-owned subsidiary of Nature’s Miracle will merge with and into Agrify...

 PRESS RELEASE

CooperCompanies to Participate in the Jefferies Global Healthcare Conf...

CooperCompanies to Participate in the Jefferies Global Healthcare Conference SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompanies CooperComp...

 PRESS RELEASE

Celcuity Inc. Reports First Quarter Financial Results and Provides Cor...

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update The Phase 3 VIKTORIA-1 trial remains on track to report topline data from PIK3CA wild type patient sub-group in the second half of 2024First patient dosed in a Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer $177.7 million in cash, cash equivalents and short-term investments expected to provide runway into the first half of 2026 Management to host webcast and conference call today, May 15, 2024, at 4:30 p.m. E...

 PRESS RELEASE

CooperCompanies to Participate in the William Blair Growth Stock Confe...

CooperCompanies to Participate in the William Blair Growth Stock Conference SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompanies CooperCompanies (Nasdaq: COO) ...

 PRESS RELEASE

Fulcrum Therapeutics Announces Recent Business Highlights and Financia...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024 ― Entered into a collaboration and ex-U.S. license agreement with Sanofi for the development and commercialization of losmapimod ― ― On track to report topline data for Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in the fourth quarter of 2024 ― ― Industry veteran, Patrick Horn M.D., Ph.D., appointed as chief medical officer ― ― Conference call and webcast scheduled for 8:00 a.m. ET today ― CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Fulcr...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch